TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 121.50
+0.50 (0.41%)
Nov 13, 2026, 1:30 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 8.07 billion as of November 13, 2026. It is the 19,254th most valuable company in the world and the 780th biggest in Taiwan. Its market cap has decreased by 24.48% in one year.
Market Cap
8.07B
Enterprise Value
6.93B
Revenue
715.30M
Global Rank
Country Rank
#780 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 8.07B, an increase of 490.02%. That is a compound annual growth rate of 12.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 8.07B | -20.99% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 8.54B |
| PharmaEngine | 7.83B |
| Tanvex BioPharma | 7.45B |
| Locus Cell | 7.35B |
| Adimmune | 7.08B |
| Acepodia | 6.97B |
| AnnJi Pharmaceutical | 6.56B |
| Polaris Group | 6.39B |